INVO Fertility (NASDAQ:IVF) versus Agilon Health (NYSE:AGL) Head-To-Head Analysis

Agilon Health (NYSE:AGL) and INVO Fertility (NASDAQ:IVF) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations and risk.

Valuation and Earnings

This table compares Agilon Health and INVO Fertility”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93 billion	0.25	-$391.35 million	($14.27)	-6.11
INVO Fertility	$7.53 million	0.20	-$25.13 million	($33.83)	-0.02

INVO Fertility has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Agilon Health and INVO Fertility, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2	7	6	0	2.27
INVO Fertility	1	0	0	1	2.50

Agilon Health currently has a consensus target price of $102.25, suggesting a potential upside of 17.35%. INVO Fertility has a consensus target price of $20.00, suggesting a potential upside of 3,289.83%. Given INVO Fertility’s stronger consensus rating and higher probable upside, analysts clearly believe INVO Fertility is more favorable than Agilon Health.

Volatility & Risk

Agilon Health has a beta of 2.98, suggesting that its stock price is 198% more volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.39, suggesting that its stock price is 139% more volatile than the S&P 500.

Insider & Institutional Ownership

12.0% of INVO Fertility shares are owned by institutional investors. 2.5% of Agilon Health shares are owned by company insiders. Comparatively, 0.4% of INVO Fertility shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Agilon Health and INVO Fertility’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Agilon Health	-3.92%	-119.38%	-16.85%
INVO Fertility	-116.29%	-85.54%	-31.05%

Summary

Agilon Health beats INVO Fertility on 8 of the 15 factors compared between the two stocks.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.